Delivery Order SPE2DB20D3101-SPE2DB25FRLU9
- Not listed
- The Defense Logistics Agency awarded a $53,875.27 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $27,497.95 delivery order to AmerisourceBergen Drug Corp for Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $4,770.06 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price delivery order was issued on August 6, 2025, with an ultimate completion date of August 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The order represents a single delivery under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $30,288.15 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $7,755.88 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitive, firm fixed-price delivery order was executed on July 18, 2025, with an ultimate completion date of July 21, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $5,883.86 delivery order to AmerisourceBergen Drug Corp for Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials on May 27, 2025, with an ultimate completion date of May 28, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $13,516.51 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials, with an ultimate completion date of August 18, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $5,639.94 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and due for completion by September 12, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $10,332.55 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials under a firm fixed-price contract. The award, issued on August 1, 2025, carries an ultimate completion date of August 4, 2025, and represents a non-competitive set-aside delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $19,427.80 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL quantities. This competitively awarded, firm fixed-price delivery order was issued on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's broader Indefinite Delivery...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRLU9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,169.26 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This firm fixed-price delivery order, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, was competitively awarded with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under a larger Indefinite Delivery Contract vehicle, specifically the DLA Troop Support Medical contract SPE2DX, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor with an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies. The company's role as a prime vendor under the DLA Troop Support Medical contract enables it to supply pharmaceuticals and medical commodities to support Defense Health Agency operations, the U.S. Coast Guard, and other government healthcare systems. This particular delivery order for Ozempic, a diabetes medication, reflects the company's demonstrated capability to fulfill federal medical supply requirements across multiple therapeutic domains through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 5/30/25 |